Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
B49VLE
|
|||
| Binder Name |
3-(4-(Dimethylamino)benzylidene)-1,3-dihydro-2H-indol-2-one
|
|||
| Synonyms |
SU 4312; SU-4312; NSC86429; NSC 86429; CHEMBL328710; 3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one; SU4312; SR-01000076222; BiomolKI_000054; BiomolKI2_000060; UPCMLD-DP118; cis-SU 4312; Lopac0_001121; BMK1-F6; BSPBio_000998; SCHEMBL1982207; UPCMLD-DP118:001; UPCMLD-DP118:002; BDBM17747; HMS1362B19; HMS1792B19; HMS1990B19; HMS3263B03; HMS3403B19; HMS3412D03; HMS3676D03; BCP20743; Tox21_501121; NSC-86429; STK946565; ZINC12339625; AKOS005640946; CCG-100658; LP01121; SDCCGSBI-0051089.P002; SU4312(NSC86429); IDI1_002094; NCGC00025170-02; NCGC00025170-03; NCGC00025170-04; NCGC00025170-05; NCGC00025170-06; NCGC00025170-07; NCGC00025170-08; NCGC00025170-09; NCGC00025170-10; NCGC00025170-11; NCGC00025170-12; NCGC00025170-14; NCGC00261806-01; B6746; EU-0101121; EC-000.2453; S 8567; (Z)-3-(4-(dimethylamino)benzylidene)indolin-2-one; SR-01000076222-1; SR-01000076222-3; BRD-K20287671-001-01-0; (3Z)-3-[(4-dimethylaminophenyl)methylene]indolin-2-one; DMBI; (Z)-3-(4-(dimethylamino)benzylidene)indolin-2-one; (3Z)-3-[[4-(dimethylamino)phenyl]methylidene]-1H-indol-2-one; (3Z)-3-[4-(dimethylamino)benzylidene]-1,3-dihydro-2H-indol-2-one; (3Z)-3-{[4-(dimethylamino)phenyl]methylidene}-2,3-dihydro-1H-indol-2-one; SU-4312; SU4312. DMBI; NSC 86429; NSC-86429; NSC86429
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H16N2O
|
|||
| Canonical SMILES |
CN(C)C1=CC=C(C=C1)/C=C\\2/C3=CC=CC=C3NC2=O
|
|||
| InChI |
1S/C17H16N2O/c1-19(2)13-9-7-12(8-10-13)11-15-14-5-3-4-6-16(14)18-17(15)20/h3-11H,1-2H3,(H,18,20)/b15-11-
|
|||
| InChIKey |
UAKWLVYMKBWHMX-PTNGSMBKSA-N
|
|||
| PubChem Compound ID | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.